2022
Predicting Uptake of the COVID Coach App Among US Military Veterans: Funnel Analysis Using a Probability-Based Panel
Jaworski BK, Taylor K, Ramsey KM, Heinz AJ, Steinmetz S, Owen JE, Tsai J, Pietrzak RH. Predicting Uptake of the COVID Coach App Among US Military Veterans: Funnel Analysis Using a Probability-Based Panel. JMIR Mental Health 2022, 9: e36217. PMID: 35245204, PMCID: PMC8985691, DOI: 10.2196/36217.Peer-Reviewed Original ResearchUS military veteransOlder veteransMental health toolsDigital mental health toolsHealth toolsOlder adultsOlder veteran populationMilitary veteransMental health conditionsMobile mental health appsCOVID-19 pandemicPandemic-related stressorsPandemic-related stressMental health difficultiesMental health concernsAdverse childhood experiencesPosttraumatic stress disorder (PTSD) symptomsProspective cohortDays of useMedian timeUS veteransNational HealthVeteran characteristicsMental health appsVeteran populationLongitudinal Trajectories of Multiple Nicotine Product Use Among Youths in the Population Assessment of Tobacco and Health Study
Simon P, Jiang Y, Buta E, Sartor CE, Krishnan-Sarin S, Gueorguieva R. Longitudinal Trajectories of Multiple Nicotine Product Use Among Youths in the Population Assessment of Tobacco and Health Study. JAMA Network Open 2022, 5: e223549. PMID: 35319763, PMCID: PMC8943628, DOI: 10.1001/jamanetworkopen.2022.3549.Peer-Reviewed Original ResearchConceptsNicotine product useCigar useTobacco usersTobacco useHealth StudyCigarette useProduct useWave 1Significant public health concernLongitudinal trajectoriesPublic health concernNon-Hispanic whitesTobacco product useLogistic regression modelsTobacco use behaviorsComplex survey designMultinomial logistic regression modelsDays of useSocioecological factorsMAIN OUTCOMESmokeless tobaccoLower oddsNicotine productsLatent class growth analysisSociodemographic factors
2021
Extended Use of the Control-IQ Closed-Loop Control System in Children With Type 1 Diabetes.
Kanapka LG, Wadwa RP, Breton MD, Ruedy KJ, Ekhlaspour L, Forlenza GP, Cengiz E, Schoelwer MJ, Jost E, Carria L, Emory E, Hsu LJ, Weinzimer SA, DeBoer MD, Buckingham BA, Oliveri M, Kollman C, Dokken BB, Cherñavvsky D, Beck RW. Extended Use of the Control-IQ Closed-Loop Control System in Children With Type 1 Diabetes. Diabetes Care 2021, 44: 473-478. PMID: 33355258, PMCID: PMC7818334, DOI: 10.2337/dc20-1729.Peer-Reviewed Original ResearchConceptsType 1 diabetesChildren 6Sensor-Augmented Pump TherapyWeeks of useDiabetic ketoacidosisDays of useGlycemic controlSAP groupSevere hypoglycemiaPump therapyClinical trialsPercentage of timeCLC groupMean TIRDiabetesFurther evaluationCohortRCTsDlWeeksChildrenDaysExtended useParticipantsKetoacidosis
2018
Safety and Performance of the Omnipod® Hybrid Closed-Loop System in Adolescents with Type 1 Diabetes over Five Days Under Free-Living Conditions
FORLENZA G, BUCKINGHAM B, SHERR J, PEYSER T, LEE J, OCONNOR J, DUMAIS B, HUYETT L, LAYNE J, LY T. Safety and Performance of the Omnipod® Hybrid Closed-Loop System in Adolescents with Type 1 Diabetes over Five Days Under Free-Living Conditions. Diabetes 2018, 67 DOI: 10.2337/db18-1376-p.Peer-Reviewed Original ResearchModerate-intensity exerciseDiabetes careGlycemic outcomesFree-living conditionsType 1 diabetesMin/dAdvisory PanelHybrid closed-loop systemStandard therapyDays of useEligible participantsAge 14.3Percentage of timeCGM useInvestigational deviceMedtronic MiniMedType 1DlTime 70Usual routineCareEli LillyOmnipodAdolescentsConcomitant reductionSafety and Performance of the Omnipod® Hybrid Closed-Loop System in Children Aged 6-12 Years with Type 1 Diabetes over Five Days Under Free-Living Conditions
SHERR J, FORLENZA G, BUCKINGHAM B, PEYSER T, LEE J, OCONNOR J, DUMAIS B, HUYETT L, LAYNE J, LY T. Safety and Performance of the Omnipod® Hybrid Closed-Loop System in Children Aged 6-12 Years with Type 1 Diabetes over Five Days Under Free-Living Conditions. Diabetes 2018, 67 DOI: 10.2337/db18-1377-p.Peer-Reviewed Original ResearchModerate-intensity exerciseDiabetes careGlycemic outcomesFree-living conditionsType 1 diabetesChildren Aged 6Min/dAdvisory PanelAge 9.9Hybrid closed-loop systemStandard therapyDays of useEligible participantsPercentage of timeCGM useAged 6Investigational deviceMedtronic MiniMedType 1DlTime 70Usual routineCareEli LillyOmnipodSafety and Performance of the Omnipod® Hybrid Closed-Loop System in Adults with Type 1 Diabetes over Five Days Under Free-Living Conditions
BUCKINGHAM B, SHERR J, FORLENZA G, PEYSER T, LEE J, OCONNOR J, DUMAIS B, HUYETT L, LAYNE J, LY T. Safety and Performance of the Omnipod® Hybrid Closed-Loop System in Adults with Type 1 Diabetes over Five Days Under Free-Living Conditions. Diabetes 2018, 67 DOI: 10.2337/db18-207-or.Peer-Reviewed Original ResearchModerate-intensity exerciseDiabetes careGlycemic outcomesFree-living conditionsType 1 diabetesMin/dAdvisory PanelHybrid closed-loop systemStandard therapyDays of useEligible participantsPercentage of timeCGM useInvestigational deviceMedtronic MiniMedType 1DlTime 70Usual routineCareEli LillyOmnipodAdultsConcomitant reductionDays
2011
Does Active Substance Use at Housing Entry Impair Outcomes in Supported Housing for Chronically Homeless Persons?
Edens EL, Mares AS, Tsai J, Rosenheck RA. Does Active Substance Use at Housing Entry Impair Outcomes in Supported Housing for Chronically Homeless Persons? Psychiatric Services 2011, 62: 171-178. PMID: 21285095, DOI: 10.1176/ps.62.2.pss6202_0171.Peer-Reviewed Original ResearchMutual influence in therapist competence and adherence to motivational enhancement therapy
Imel ZE, Baer JS, Martino S, Ball SA, Carroll KM. Mutual influence in therapist competence and adherence to motivational enhancement therapy. Drug And Alcohol Dependence 2011, 115: 229-236. PMID: 21227601, PMCID: PMC3397170, DOI: 10.1016/j.drugalcdep.2010.11.010.Peer-Reviewed Original ResearchMeSH KeywordsBehavior, AddictiveClinical CompetenceCounselingFemaleHealth PersonnelHumansMaleMotivationMulticenter Studies as TopicPatient Acceptance of Health CarePatient ComplianceProfessional CompetenceProfessional-Patient RelationsPsychotherapyRandomized Controlled Trials as TopicSeverity of Illness IndexTreatment OutcomeConceptsMotivational enhancement therapyClinical trialsTherapist adherenceEnhancement therapyMulti-site clinical trialLarge multi-site clinical trialDays of useTreatment protocolTherapists' caseloadsAdherenceTherapist competenceTrialsTherapist performanceClient severityTherapyCaseloadTherapistsThree-level multilevel models
2005
Respiratory effects of marijuana and tobacco use in a U.S. sample
Moore BA, Augustson EM, Moser RP, Budney AJ. Respiratory effects of marijuana and tobacco use in a U.S. sample. Journal Of General Internal Medicine 2005, 20: 33-37. PMID: 15693925, PMCID: PMC1490047, DOI: 10.1111/j.1525-1497.2004.40081.x.Peer-Reviewed Original ResearchConceptsChronic bronchitisRespiratory symptomsRespiratory effectsTobacco useMarijuana smokingSelf-reported respiratory symptomsSubstantial public health benefitsMarijuana useShortness of breathNutrition Examination SurveyThird National HealthAdults ages 20Public health benefitsRespiratory health problemsCurrent marijuana useCurrent asthmaPhlegm productionChest findingsDays of useTobacco smokingExamination SurveyRespiratory healthNational HealthTobacco usersHealth problems
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply